Yüklüyor......

New agents for AML and MDS

The heterogeneity of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has led to a multiplicity of treatments, from cytotoxic agents to signal transduction modulators, cell cycle inhibitors, and epigenetic therapies. While some have shown promising initial results, the outlook for AM...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Grant, Steven
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2793080/
https://ncbi.nlm.nih.gov/pubmed/19959100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2009.08.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!